Neuroimaging, the ischaemic penumbra, and selection of patients for acute stroke therapy

[1]  H. Diener,et al.  Imaging in cerebrovascular disease , 2001, Current opinion in neurology.

[2]  Peter Sandercock,et al.  The International Stroke Trial (IST): a randomised trial of aspirin, subcutaneous heparin, both, or neither among 19 435 patients with acute ischaemic stroke , 1997, The Lancet.

[3]  S. Warach,et al.  Diffusion-weighted MRI as an evolving standard of care in acute stroke , 2000, Neurology.

[4]  J T Kuikka,et al.  Combined diffusion and perfusion MRI with correlation to single-photon emission CT in acute ischemic stroke. Ischemic penumbra predicts infarct growth. , 1999, Stroke.

[5]  S. Warach,et al.  Effect of citicoline on ischemic lesions as measured by diffusion‐weighted magnetic resonance imaging , 2000 .

[6]  Leif Østergaard,et al.  Diffusion and perfusion MR imaging in acute ischemic stroke: a comparison to SPECT , 2001, Comput. Methods Programs Biomed..

[7]  M. Fisher,et al.  The penumbra, therapeutic time window and acute ischaemic stroke. , 1995, Bailliere's clinical neurology.

[8]  K Minematsu,et al.  Reversible Focal Ischemic Injury Demonstrated by Diffusion‐Weighted Magnetic Resonance Imaging in Rats , 1992, Stroke.

[9]  W D Heiss,et al.  Which targets are relevant for therapy of acute ischemic stroke? , 1999, Stroke.

[10]  R. Kummer.  Effect of training in reading CT scans on patient selection for ECASS II , 1998 .

[11]  W D Heiss,et al.  Ischemic Penumbra: Evidence From Functional Imaging in Man , 2000, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[12]  W. Heiss,et al.  Dynamic Penumbra Demonstrated by Sequential Multitracer PET after Middle Cerebral Artery Occlusion in Cats , 1994, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[13]  J Star-Lack,et al.  High spatial resolution 1H‐MRSI and segmented MRI of cortical gray matter and subcortical white matter in three regions of the human brain , 1999, Magnetic resonance in medicine.

[14]  T. Neumann-Haefelin,et al.  Serial MRI after transient focal cerebral ischemia in rats: dynamics of tissue injury, blood-brain barrier damage, and edema formation. , 2000, Stroke.

[15]  K Ohta,et al.  Repeat Positron Emission Tomographic Studies in Transient Middle Cerebral Artery Occlusion in Cats: Residual Perfusion and Efficacy of Postischemic Reperfusion , 1997, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[16]  F. Sharp,et al.  Induction of heat shock hsp70 mRNA and HSP70 kDa protein in neurons in the ‘penumbra’ following focal cerebral ischemia in the rat , 1993, Brain Research.

[17]  Richard S. J. Frackowiak,et al.  Macrophage and Astrocyte Populations in Relation to [3H]PK 11195 Binding in Rat Cerebral Cortex following a Local Ischaemic Lesion , 1991, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[18]  M Fisher,et al.  Evolving stroke and the ischemic penumbra , 1996, Neurology.

[19]  Reto Meuli,et al.  CT perfusion scanning with deconvolution analysis: pilot study in patients with acute middle cerebral artery stroke. , 2002, Radiology.

[20]  D Petersen,et al.  Interobserver agreement in assessing early CT signs of middle cerebral artery infarction. , 1996, AJNR. American journal of neuroradiology.

[21]  A. Thiel,et al.  Penumbral probability thresholds of cortical flumazenil binding and blood flow predicting tissue outcome in patients with cerebral ischaemia. , 2001, Brain : a journal of neurology.

[22]  G J Barker,et al.  Quantitative analysis of short echo time 1H‐MRSI of cerebral gray and white matter , 2000, Magnetic resonance in medicine.

[23]  G. Donnan,et al.  Changes in cerebral tissue perfusion during the first 48 hours of ischaemic stroke: relation to clinical outcome. , 1996, Journal of neurology, neurosurgery, and psychiatry.

[24]  S M Davis,et al.  Prediction of stroke outcome with echoplanar perfusion- and diffusion-weighted MRI , 1998, Neurology.

[25]  D. Abbott,et al.  Identifying hypoxic tissue after acute ischemic stroke using PET and 18F-fluoromisonidazole , 1998, Neurology.

[26]  G. Semenza,et al.  Purification and Characterization of Hypoxia-inducible Factor 1 (*) , 1995, The Journal of Biological Chemistry.

[27]  P. Barber,et al.  Prediction of the Final Infarct Volume within 6 h of Stroke Using Single Photon Emission Computed Tomography with Technetium-99m Hexamethylpropylene Amine Oxime , 2001, Cerebrovascular Diseases.

[28]  L Bozzao,et al.  Acute stroke: usefulness of early CT findings before thrombolytic therapy. , 1997, Radiology.

[29]  Zheng-Ming Chen,et al.  CAST: randomised placebo-controlled trial of early aspirin use in 20 000 patients with acute ischaemic stroke , 1997, The Lancet.

[30]  P. Barber,et al.  Absent middle cerebral artery flow predicts the presence and evolution of the ischemic penumbra , 1999, Neurology.

[31]  G. Albers,et al.  Applications of diffusion–perfusion magnetic resonance imaging in acute ischemic stroke , 1999, Neurology.

[32]  M E Moseley,et al.  New magnetic resonance imaging methods for cerebrovascular disease: Emerging clinical applications , 2000, Annals of neurology.

[33]  J. Thiran,et al.  Simultaneous measurement of regional cerebral blood flow by perfusion CT and stable xenon CT: a validation study. , 2001, AJNR. American journal of neuroradiology.

[34]  G. Schlaug,et al.  Enlargement of human cerebral ischemic lesion volumes measured by diffusion‐weighted magnetic resonance imaging , 1997, Annals of neurology.

[35]  F. Blankenberg,et al.  Apoptotic cell death: its implications for imaging in the next millennium , 2000, European Journal of Nuclear Medicine.

[36]  Jean-Claude Baron,et al.  Mapping the Ischaemic Penumbra with PET: Implications for Acute Stroke Treatment , 1999, Cerebrovascular Diseases.

[37]  G. Donnan.  Investigation of patients with stroke and transient ischaemic attacks , 1992, The Lancet.

[38]  P. Barber,et al.  Combined 1H MR spectroscopy and diffusion-weighted MRI improves the prediction of stroke outcome , 2000, Neurology.

[39]  T. Neumann-Haefelin,et al.  Reversal of Early Diffusion-Weighted Magnetic Resonance Imaging Abnormalities Does Not Necessarily Reflect Tissue Salvage in Experimental Cerebral Ischemia , 2001, Stroke.

[40]  M. Wiesmann,et al.  Detection of hyperacute parenchymal hemorrhage of the brain using echo-planar T2*-weighted and diffusion-weighted MRI , 2001, European Radiology.

[41]  K. Muir,et al.  Neuroprotection for acute stroke: making clinical trials work. , 1999, Stroke.

[42]  G. Hamann,et al.  Ischaemic damage of brain microvessels: inherent risks for thrombolytic treatment in stroke , 1998, Journal of neurology, neurosurgery, and psychiatry.

[43]  S. Warach,et al.  Magnetic Resonance Imaging of Acute Stroke , 1998, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[44]  A. Demchuk,et al.  Validity and reliability of a quantitative computed tomography score in predicting outcome of hyperacute stroke before thrombolytic therapy , 2000, The Lancet.

[45]  S M Davis,et al.  Identification of major ischemic change. Diffusion-weighted imaging versus computed tomography. , 1999, Stroke.

[46]  R B Banati,et al.  Thalamic microglial activation in ischemic stroke detected in vivo by PET and [11C]PK11195 , 2000, Neurology.

[47]  R J Seitz,et al.  Diffusion- and perfusion-weighted MRI. The DWI/PWI mismatch region in acute stroke. , 1999, Stroke.

[48]  M D Ginsberg,et al.  The acute ischemic penumbra: topography, life span, and therapeutic response. , 1999, Acta neurochirurgica. Supplement.

[49]  P. Doevendans,et al.  Visualisation of cell death in vivo in patients with acute myocardial infarction , 2000, The Lancet.

[50]  G. Donnan,et al.  Salvaging The Ischaemic Penumbra: More Than Just Reperfusion? , 2002, Clinical and experimental pharmacology & physiology.

[51]  H J Tochon-Danguy,et al.  The fate of hypoxic tissue on 18F‐fluoromisonidazole positron emission tomography after ischemic stroke , 2000, Annals of neurology.

[52]  J. Grotta,et al.  Lack of clinical significance of early ischemic changes on computed tomography in acute stroke. , 2001, JAMA.

[53]  B. Siesjö,et al.  Thresholds in cerebral ischemia - the ischemic penumbra. , 1981, Stroke.

[54]  C. Weiller,et al.  Severe ADC Decreases Do Not Predict Irreversible Tissue Damage In Humans , 2002, Stroke.

[55]  M. Hommel,et al.  Streptokinase in acute ischemic stroke: an individual patient data meta-analysis : The Thrombolysis in Acute Stroke Pooling Project. , 2000, Stroke.

[56]  P. Vespa,et al.  Predictors of Hemorrhagic Transformation in Patients Receiving Intra-Arterial Thrombolysis , 2002, Stroke.

[57]  T Moulin,et al.  Hemorrhagic transformation in acute ischemic stroke. The MAST-E study. MAST-E Group. , 1999, Stroke.

[58]  G. Donnan,et al.  Baseline Blood Pressure but Not Early Computed Tomography Changes Predicts Major Hemorrhage After Streptokinase in Acute Ischemic Stroke , 2002, Stroke.

[59]  K. Lees,et al.  The rationale for new therapies in acute ischaemic stroke , 1996, Journal of clinical pharmacy and therapeutics.

[60]  W. Hacke,et al.  Monitoring intravenous recombinant tissue plasminogen activator thrombolysis for acute ischemic stroke with diffusion and perfusion MRI. , 2000, Stroke.

[61]  Erich Bluhmki,et al.  Risk Factors for Severe Hemorrhagic Transformation in Ischemic Stroke Patients Treated With Recombinant Tissue Plasminogen Activator: A Secondary Analysis of the European-Australasian Acute Stroke Study (ECASS II) , 2001, Stroke.

[62]  T Jones,et al.  Serial observations on the pathophysiology of acute stroke. The transition from ischaemia to infarction as reflected in regional oxygen extraction. , 1983, Brain : a journal of neurology.

[63]  Joseph P. Broderick,et al.  Tissue plasminogen activator for acute ischemic stroke. The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group. , 1995 .

[64]  R. Gonzalez,et al.  Acute stroke: improved nonenhanced CT detection--benefits of soft-copy interpretation by using variable window width and center level settings. , 1999, Radiology.

[65]  Stephen Rose,et al.  Diffusion‐ and perfusion‐weighted MRI response to thrombolysis in stroke , 2002, Annals of neurology.

[66]  M. Nedergaard,et al.  Neuronal injury in the infarct border: a neuropathological study in the rat , 2004, Acta Neuropathologica.

[67]  A. Villringer,et al.  MRI of small human stroke shows reversible diffusion changes in subcortical gray matter , 2000, Neuroreport.

[68]  M. Ginsberg,et al.  The ischemic penumbra, injury thresholds, and the therapeutic window for acute stroke , 1994, Annals of neurology.

[69]  F. Blankenberg,et al.  99mTc Annexin V Imaging of Neonatal Hypoxic Brain Injury , 2000, Stroke.

[70]  S M Davis,et al.  Pathophysiological topography of acute ischemia by combined diffusion-weighted and perfusion MRI. , 1999, Stroke.

[71]  P. Langhorne,et al.  Do stroke units save lives? , 1993, The Lancet.

[72]  G. Cosnard,et al.  Resolution of early diffusion-weighted and FLAIR MRI abnormalities in a patient with TIA , 1999, Neurology.

[73]  G. Donnan.  Lifesaving for stroke , 1993, The Lancet.

[74]  A. Lang,et al.  Double-blind evaluation of subthalamic nucleus deep brain stimulation in advanced Parkinson's disease , 1998, Neurology.

[75]  M. Knauth,et al.  Comparison of CT with diffusion-weighted MRI in patients with hyperacute stroke , 2001, Neuroradiology.

[76]  Rudolf Graf,et al.  The ischemic penumbra , 1994, Current opinion in neurology.

[77]  R. Kummer.  CT of Acute Cerebral Ischemia , 2000 .

[78]  J. Baron,et al.  Which targets are relevant for therapy of acute ischemic stroke? , 2000, Stroke.

[79]  C. Sotak,et al.  Temporal evolution of ischemic injury evaluated with diffusion-, perfusion-, and T2-weighted MRI , 2000, Neurology.

[80]  F Di Salle,et al.  Diffusion MRI in patients with transient ischemic attacks. , 1999, Stroke.

[81]  Newell,et al.  Supplement to the AHA guidelines for the management of transient ischemic attacks , 2000, Stroke.

[82]  D. Darby,et al.  Results from the pilot phase of the Echoplanar Imaging Thrombolysis Evaluation Trial (EPITHET) , 2002 .

[83]  David C. Reutens,et al.  Statistical Parametric Mapping of Hypoxic Tissue Identified by [18F]Fluoromisonidazole and Positron Emission Tomography Following Acute Ischemic Stroke , 2002, NeuroImage.

[84]  S. Warach.  Thrombolysis in stroke beyond three hours: Targeting patients with diffusion and perfusion MRI , 2002, Annals of neurology.

[85]  F. Sharp,et al.  Multiple Molecular Penumbras after Focal Cerebral Ischemia , 2000, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[86]  Andrew M. Demchuk,et al.  Markers of Increased Risk of Intracerebral Hemorrhage After Intravenous Recombinant Tissue Plasminogen Activator Therapy for Acute Ischemic Stroke in Clinical Practice: The Multicenter rt-PA Acute Stroke Survey , 2002, Circulation.

[87]  S. Warach.  New imaging strategies for patient selection for thrombolytic and neuroprotective therapies , 2001, Neurology.

[88]  J. Kucharczyk,et al.  Early detection of regional cerebral ischemia in cats: Comparison of diffusion‐ and T2‐weighted MRI and spectroscopy , 1990, Magnetic resonance in medicine.

[89]  K Wienhard,et al.  Progressive Derangement of Periinfarct Viable Tissue in Ischemic Stroke , 1992, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[90]  Jean-Philippe Thiran,et al.  Prognostic accuracy of cerebral blood flow measurement by perfusion computed tomography, at the time of emergency room admission, in acute stroke patients , 2002, Annals of neurology.

[91]  G Di Chiro,et al.  Histopathologic correlates of abnormal water diffusion in cerebral ischemia: diffusion-weighted MR imaging and light and electron microscopic study. , 1993, Radiology.

[92]  W Hacke,et al.  A standardized MRI stroke protocol: comparison with CT in hyperacute intracerebral hemorrhage. , 1999, Stroke.

[93]  M. Moskowitz,et al.  Pathobiology of ischaemic stroke: an integrated view , 1999, Trends in Neurosciences.

[94]  W. Hacke,et al.  Hemorrhagic Transformation of Ischemic Brain Tissue: Asymptomatic or Symptomatic? , 2001, Stroke.

[95]  Fausto Viader,et al.  Spontaneous neurological recovery after stroke and the fate of the ischemic penumbra , 1996, Annals of neurology.

[96]  J. Broderick,et al.  Factors Related to Intracranial Hematoma Formation in Patients Receiving Tissue‐Type Plasminogen Activator forAcute Ischemic Stroke , 1994, Stroke.

[97]  M E Moseley,et al.  Evaluation of early reperfusion and IV tPA therapy using diffusion- and perfusion-weighted MRI , 1999, Neurology.

[98]  M. Kaste,et al.  Randomised double-blind placebo-controlled trial of thrombolytic therapy with intravenous alteplase in acute ischaemic stroke (ECASS II) , 1998, The Lancet.

[99]  K Wienhard,et al.  Use of PET Methods for Measurement of Cerebral Energy Metabolism and Hemodynamics in Cerebrovascular Disease , 1989, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[100]  R. Schmidt-Kastner,et al.  Cortical spreading depression activates trophic factor expression in neurons and astrocytes and protects against subsequent focal brain ischemia , 1998, Brain Research.

[101]  W D Heiss,et al.  Role of PET and SPECT in the assessment of ischemic cerebrovascular disease. , 1993, Cerebrovascular and brain metabolism reviews.

[102]  M. Hommel,et al.  Significance of Early CT Signs in Acute Stroke , 2002, Cerebrovascular Diseases.

[103]  P D Lyden,et al.  Agreement and variability in the interpretation of early CT changes in stroke patients qualifying for intravenous rtPA therapy. , 1999, Stroke.

[104]  G. Donnan,et al.  Limiting Neurological Damage After Stroke , 1999, Drugs & aging.

[105]  M. Kaste,et al.  Intravenous thrombolysis with recombinant tissue plasminogen activator for acute hemispheric stroke. The European Cooperative Acute Stroke Study (ECASS) , 1995, JAMA.

[106]  Gary Duckwiler,et al.  Thrombolytic reversal of acute human cerebral ischemic injury shown by diffusion/perfusion magnetic resonance imaging , 2000, Annals of neurology.